MARTELLUCCI, IGNAZIO
 Distribuzione geografica
Continente #
NA - Nord America 1.536
EU - Europa 1.358
AS - Asia 678
SA - Sud America 99
AF - Africa 9
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 3.682
Nazione #
US - Stati Uniti d'America 1.506
RU - Federazione Russa 383
GB - Regno Unito 298
SG - Singapore 274
CN - Cina 250
IE - Irlanda 182
IT - Italia 104
UA - Ucraina 88
BR - Brasile 85
SE - Svezia 85
DE - Germania 77
FR - Francia 56
HK - Hong Kong 48
FI - Finlandia 38
VN - Vietnam 31
KR - Corea 29
IN - India 17
CA - Canada 16
ES - Italia 11
MX - Messico 11
BE - Belgio 7
TR - Turchia 7
PL - Polonia 6
BD - Bangladesh 5
CI - Costa d'Avorio 5
LT - Lituania 5
NL - Olanda 5
IL - Israele 4
VE - Venezuela 4
AR - Argentina 3
AT - Austria 3
JP - Giappone 3
PE - Perù 3
CO - Colombia 2
CZ - Repubblica Ceca 2
IQ - Iraq 2
IR - Iran 2
PA - Panama 2
AE - Emirati Arabi Uniti 1
AO - Angola 1
AZ - Azerbaigian 1
BH - Bahrain 1
BW - Botswana 1
BY - Bielorussia 1
CH - Svizzera 1
EU - Europa 1
GR - Grecia 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
KI - Kiribati 1
LK - Sri Lanka 1
LV - Lettonia 1
PK - Pakistan 1
PT - Portogallo 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
TJ - Tagikistan 1
TN - Tunisia 1
UY - Uruguay 1
ZA - Sudafrica 1
Totale 3.682
Città #
Southend 262
Dallas 185
Dublin 178
Fairfield 175
Singapore 160
Ashburn 123
Moscow 100
Woodbridge 86
Chandler 84
Santa Clara 83
Beijing 80
Seattle 75
Jacksonville 71
Houston 68
Wilmington 63
Cambridge 48
Hong Kong 48
Ann Arbor 44
Siena 40
New York 35
Princeton 31
Munich 30
Nanjing 30
Hefei 29
Seoul 29
Los Angeles 27
Council Bluffs 20
Milan 18
Helsinki 17
Shanghai 17
Ho Chi Minh City 13
Boardman 12
San Mateo 12
Florence 11
San Diego 11
London 10
Málaga 9
São Paulo 9
Hanoi 8
Turku 8
Brussels 7
Denver 7
Chicago 6
Dearborn 6
Düsseldorf 6
Nanchang 6
Warsaw 6
Abidjan 5
Amsterdam 5
Boston 5
Buffalo 5
Montreal 5
Nuremberg 5
Redondo Beach 5
San Francisco 5
Toronto 5
Ankara 4
Bengaluru 4
Brooklyn 4
Cagliari 4
Changsha 4
Dong Ket 4
Hebei 4
Ningbo 4
Poplar 4
Renton 4
Aguascalientes 3
Atlanta 3
Belo Horizonte 3
Bologna 3
Curitiba 3
Fremont 3
Hangzhou 3
Kunming 3
Mexico City 3
Phoenix 3
Stockholm 3
The Dalles 3
Tianjin 3
Tokyo 3
Vinci 3
Washington 3
Auburn Hills 2
Bauru 2
Brasília 2
Brno 2
Columbus 2
Falkenstein 2
Gravatá 2
Hortolândia 2
Jiaxing 2
Lauterbourg 2
Lima 2
Menlo Park 2
Mumbai 2
Norfolk 2
Norwalk 2
Ottawa 2
Panama City 2
Portsmouth 2
Totale 2.572
Nome #
Systemic inflammatory status at baseline predicts bevacizumab benefit in advanced non-small cell lung cancer patients 310
Efficacy and Safety of Regorafenib With 2/1 Schedule for Patients ≥ 75 Years With Metastatic Colorectal Cancer (mCRC) After Failure of 2 Lines of Chemotherapy 287
A62Effectiveness and resulting surgical behavior after neoadjuvant chemotherapy in locally advanced breast cancer: our experience 267
Two-point-NGS analysis of cancer genes in cell-free DNA of metastatic cancer patients 227
A novel metronomic chemotherapy regimen of weekly platinum and daily oral etoposide in high-risk non-small cell lung cancer patients 221
Bevacizumab and weekly Doxetacel in patients with metastatic castrate-resistant prostate cancer previously exposed to Docetaxel 220
Cisplatin, etoposide, and bevacizumab regimen followed by oral etoposide and bevacizumab maintenance treatment in patients with extensive-stage small cell lung cancer: A single-institution experience 214
Effects of intravenous Zoledronic acid and oral ibandronate on early changes in markers of bone turnover in patients with bone metastases from NSCLC 203
Metronomic antiangiogenetic biochemotherapy of non-small cell lung cancer patients with fractioned cisplatinum, oral etoposide and bevacizumab: phase IB/II study 196
Immunity feedback and clinical outcome in colon cancer patients undergoing chemoimmunotherapy with gemcitabine + FOLFOX followed by subcutaneous granulocyte macrophage colony-stimulating factor and aldesleukin (GOLFIG-1 Trial) 192
Phase II trial of bevacizumab and dose/dense chemotherapy with cisplatin and metronomic daily oral etoposide in advanced non-small-cell-lung cancer patients 190
Thymidine phosphorylase expression in metastatic sites is predictive for response in patients with colorectal cancer treated with continuous oral capecitabine and biweekly oxaliplatin 181
Dose/dense metronomic chemotherapy with fractioned cisplatin and oral daily etoposide enhances the anti-angiogenic effects of bevacizumab and has strong antitumor activity in advanced non-small-cell-lung cancer patients 180
First-line pharmacotherapies and survival among patients diagnosed with non-resectable NSCLC: a real-life setting study with gender prospective 151
Gemcitabine plus nab-paclitaxel followed by maintenance treatment with gemcitabine alone as first-line treatment for older adults with locally advanced or metastatic pancreatic cancer 147
Porcelain gallbladder and its relationship to cancer 131
Sjögren's syndrome and aromatase inhibitors treatment: is there a link? 127
Metronomic antiangiogenetic biochemotherapy of non-small cell lung cancer patients with fractionated cisplatimum, oral etoposide, and bevacizumab 118
Head and Neck Carcinoma and biomarker profiling: searching tumor identity card. 92
Head and Neck Carcinoma and biomarker profiling: searching tumor identity card. 68
Early psychological intervention in cancer patients: effects on emotional distress 7
null 3
Totale 3.732
Categoria #
all - tutte 11.597
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.597


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021243 0 0 0 0 0 57 7 56 33 34 33 23
2021/2022253 22 20 14 19 15 11 9 10 12 31 33 57
2022/2023319 21 23 47 40 27 63 5 29 33 10 14 7
2023/2024293 5 5 24 13 10 88 105 9 3 12 3 16
2024/2025600 33 27 63 38 73 33 8 19 74 27 77 128
2025/20261.071 107 189 147 232 386 10 0 0 0 0 0 0
Totale 3.732